Document is current
Any future updates will be listed below
-
Authors
Miura, John
Karakousis, Giorgos
- License Information
-
More Information
Article History
Received: 8 November 2021
Accepted: 10 November 2021
First Online: 23 November 2021
Disclosures
: Giorgos Karakousis is the Principal Investigator of an investigator-initiated Neoadjuvant Stage IIB/C clinical trial with institutional support from Merck.
Free to read: This content has been made available to all.
